14th Biologics Manufacturing Korea 2025

 

The 14th Biologics Manufacturing Korea 2025 is set to be the leading platform for collaboration, knowledge sharing, and strategic partnerships in Korea’s biopharma industry.

This year’s conference will spotlight critical advancements in upstream processing, the integration of automation and AI in biomanufacturing, regulatory insights for biosimilars, and innovative solutions for downstream processing and supply chain optimization.

Attendees will have the opportunity to connect with key industry players, including leaders from Samsung Biologics, Celltrion, SK bioscience, Hanmi Pharmaceuticals, Lotte Biologics, and many more.

To receive a 15% discount, please use the code “BA15” at checkout.

More Info

---

---